rs11592273

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000195.5(HPS1):​c.847G>T​(p.Gly283Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0662 in 1,613,760 control chromosomes in the GnomAD database, including 4,014 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G283R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.050 ( 238 hom., cov: 33)
Exomes 𝑓: 0.068 ( 3776 hom. )

Consequence

HPS1
NM_000195.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.55

Publications

19 publications found
Variant links:
Genes affected
HPS1 (HGNC:5163): (HPS1 biogenesis of lysosomal organelles complex 3 subunit 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is a component of three different protein complexes termed biogenesis of lysosome-related organelles complex (BLOC)-3, BLOC4, and BLOC5. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 1. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on chromosome 22. [provided by RefSeq, Aug 2015]
HPS1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Hermansky-Pudlak syndrome with pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026259422).
BP6
Variant 10-98429811-C-A is Benign according to our data. Variant chr10-98429811-C-A is described in ClinVar as Benign. ClinVar VariationId is 21108.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0741 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPS1NM_000195.5 linkc.847G>T p.Gly283Trp missense_variant Exon 9 of 20 ENST00000361490.9 NP_000186.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPS1ENST00000361490.9 linkc.847G>T p.Gly283Trp missense_variant Exon 9 of 20 1 NM_000195.5 ENSP00000355310.4 Q92902-1
ENSG00000289758ENST00000699159.1 linkn.*227-169G>T intron_variant Intron 8 of 23 ENSP00000514167.1 A0A8V8TP71

Frequencies

GnomAD3 genomes
AF:
0.0502
AC:
7645
AN:
152196
Hom.:
238
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0221
Gnomad AMI
AF:
0.0702
Gnomad AMR
AF:
0.0361
Gnomad ASJ
AF:
0.0234
Gnomad EAS
AF:
0.000772
Gnomad SAS
AF:
0.0167
Gnomad FIN
AF:
0.0641
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0758
Gnomad OTH
AF:
0.0492
GnomAD2 exomes
AF:
0.0487
AC:
12218
AN:
251054
AF XY:
0.0489
show subpopulations
Gnomad AFR exome
AF:
0.0227
Gnomad AMR exome
AF:
0.0266
Gnomad ASJ exome
AF:
0.0188
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0642
Gnomad NFE exome
AF:
0.0758
Gnomad OTH exome
AF:
0.0553
GnomAD4 exome
AF:
0.0679
AC:
99201
AN:
1461446
Hom.:
3776
Cov.:
34
AF XY:
0.0663
AC XY:
48199
AN XY:
727046
show subpopulations
African (AFR)
AF:
0.0190
AC:
635
AN:
33480
American (AMR)
AF:
0.0274
AC:
1225
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0213
AC:
558
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0141
AC:
1220
AN:
86256
European-Finnish (FIN)
AF:
0.0684
AC:
3627
AN:
53032
Middle Eastern (MID)
AF:
0.0442
AC:
255
AN:
5766
European-Non Finnish (NFE)
AF:
0.0793
AC:
88151
AN:
1111960
Other (OTH)
AF:
0.0584
AC:
3525
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
5323
10646
15969
21292
26615
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3204
6408
9612
12816
16020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0502
AC:
7645
AN:
152314
Hom.:
238
Cov.:
33
AF XY:
0.0488
AC XY:
3635
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0220
AC:
915
AN:
41588
American (AMR)
AF:
0.0361
AC:
552
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0234
AC:
81
AN:
3468
East Asian (EAS)
AF:
0.000773
AC:
4
AN:
5172
South Asian (SAS)
AF:
0.0168
AC:
81
AN:
4834
European-Finnish (FIN)
AF:
0.0641
AC:
681
AN:
10618
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0758
AC:
5157
AN:
68012
Other (OTH)
AF:
0.0487
AC:
103
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
377
754
1130
1507
1884
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0615
Hom.:
659
Bravo
AF:
0.0472
TwinsUK
AF:
0.0809
AC:
300
ALSPAC
AF:
0.0693
AC:
267
ESP6500AA
AF:
0.0302
AC:
133
ESP6500EA
AF:
0.0758
AC:
652
ExAC
AF:
0.0511
AC:
6205
EpiCase
AF:
0.0696
EpiControl
AF:
0.0740

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome 1 Benign:3
Sep 17, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gly283Trp in exon 9 of HPS1: This variant is not expected to have clinical signi ficance because it has been identified in 7.6% (652/8600) of European American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs11592273). -

Hermansky-Pudlak syndrome Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
0.29
DANN
Benign
0.78
DEOGEN2
Benign
0.076
T;T;T;.
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.095
N
LIST_S2
Benign
0.35
.;.;T;T
MetaRNN
Benign
0.0026
T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.4
L;L;L;L
PhyloP100
-1.5
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.1
N;N;.;N
REVEL
Benign
0.12
Sift
Benign
0.034
D;D;.;D
Sift4G
Benign
0.079
T;T;T;D
Polyphen
0.99
D;D;D;P
Vest4
0.14
MPC
0.49
ClinPred
0.038
T
GERP RS
-5.5
Varity_R
0.029
gMVP
0.22
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11592273; hg19: chr10-100189568; COSMIC: COSV57266763; COSMIC: COSV57266763; API